vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and MIAMI INTERNATIONAL HOLDINGS, INC. (MIAX). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $339.8M, roughly 1.5× MIAMI INTERNATIONAL HOLDINGS, INC.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -30.0%, a 36.9% gap on every dollar of revenue. On growth, MIAMI INTERNATIONAL HOLDINGS, INC. posted the faster year-over-year revenue change (22.8% vs -1.7%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

Miami Air International was an American charter airline based in Miami-Dade County, Florida, United States. It operated worldwide passenger charter flights for diverse groups including cruise operators, professional sports teams and the United States military. It was based at Miami International Airport. Miami Air's customers included incentive groups, sports teams, Fortune 500 companies, major cruise lines, entertainers, political candidates and the United States government. Under the Civil ...

MD vs MIAX — Head-to-Head

Bigger by revenue
MD
MD
1.5× larger
MD
$493.8M
$339.8M
MIAX
Growing faster (revenue YoY)
MIAX
MIAX
+24.5% gap
MIAX
22.8%
-1.7%
MD
Higher net margin
MD
MD
36.9% more per $
MD
6.8%
-30.0%
MIAX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MD
MD
MIAX
MIAX
Revenue
$493.8M
$339.8M
Net Profit
$33.7M
$-102.1M
Gross Margin
32.2%
Operating Margin
9.9%
-0.1%
Net Margin
6.8%
-30.0%
Revenue YoY
-1.7%
22.8%
Net Profit YoY
10.5%
-3086.0%
EPS (diluted)
$0.40
$-1.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
MIAX
MIAX
Q4 25
$493.8M
Q3 25
$492.9M
$339.8M
Q2 25
$468.8M
Q1 25
$458.4M
Q4 24
$502.4M
Q3 24
$511.2M
$276.7M
Q2 24
$504.3M
Q1 24
$495.1M
Net Profit
MD
MD
MIAX
MIAX
Q4 25
$33.7M
Q3 25
$71.7M
$-102.1M
Q2 25
$39.3M
Q1 25
$20.7M
Q4 24
$30.5M
Q3 24
$19.4M
$-3.2M
Q2 24
$-153.0M
Q1 24
$4.0M
Gross Margin
MD
MD
MIAX
MIAX
Q4 25
Q3 25
32.2%
Q2 25
Q1 25
Q4 24
Q3 24
25.1%
Q2 24
Q1 24
Operating Margin
MD
MD
MIAX
MIAX
Q4 25
9.9%
Q3 25
13.8%
-0.1%
Q2 25
12.8%
Q1 25
7.0%
Q4 24
7.8%
Q3 24
6.6%
-0.4%
Q2 24
-31.3%
Q1 24
3.2%
Net Margin
MD
MD
MIAX
MIAX
Q4 25
6.8%
Q3 25
14.5%
-30.0%
Q2 25
8.4%
Q1 25
4.5%
Q4 24
6.1%
Q3 24
3.8%
-1.2%
Q2 24
-30.3%
Q1 24
0.8%
EPS (diluted)
MD
MD
MIAX
MIAX
Q4 25
$0.40
Q3 25
$0.84
$-1.46
Q2 25
$0.46
Q1 25
$0.24
Q4 24
$0.37
Q3 24
$0.23
$-0.05
Q2 24
$-1.84
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
MIAX
MIAX
Cash + ST InvestmentsLiquidity on hand
$375.2M
$401.5M
Total DebtLower is stronger
$570.5M
$6.5M
Stockholders' EquityBook value
$865.9M
$831.9M
Total Assets
$2.2B
$1.2B
Debt / EquityLower = less leverage
0.66×
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
MIAX
MIAX
Q4 25
$375.2M
Q3 25
$340.1M
$401.5M
Q2 25
$224.7M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
$125.1M
Q2 24
$19.4M
Q1 24
$8.0M
Total Debt
MD
MD
MIAX
MIAX
Q4 25
$570.5M
Q3 25
$577.2M
$6.5M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
MIAX
MIAX
Q4 25
$865.9M
Q3 25
$890.7M
$831.9M
Q2 25
$833.8M
Q1 25
$789.2M
Q4 24
$764.9M
Q3 24
$732.5M
$351.4M
Q2 24
$706.5M
Q1 24
$856.2M
Total Assets
MD
MD
MIAX
MIAX
Q4 25
$2.2B
Q3 25
$2.2B
$1.2B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.2B
Q3 24
$2.1B
Q2 24
$2.0B
Q1 24
$2.2B
Debt / Equity
MD
MD
MIAX
MIAX
Q4 25
0.66×
Q3 25
0.65×
0.01×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
MIAX
MIAX
Operating Cash FlowLast quarter
$114.1M
$120.8M
Free Cash FlowOCF − Capex
$102.2M
FCF MarginFCF / Revenue
30.1%
Capex IntensityCapex / Revenue
5.5%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
MIAX
MIAX
Q4 25
$114.1M
Q3 25
$137.3M
$120.8M
Q2 25
$137.2M
Q1 25
$-117.5M
Q4 24
$133.0M
Q3 24
$91.8M
Q2 24
$107.0M
Q1 24
$-125.2M
Free Cash Flow
MD
MD
MIAX
MIAX
Q4 25
Q3 25
$102.2M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
MD
MD
MIAX
MIAX
Q4 25
Q3 25
30.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
MD
MD
MIAX
MIAX
Q4 25
Q3 25
5.5%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
MD
MD
MIAX
MIAX
Q4 25
3.39×
Q3 25
1.91×
Q2 25
3.49×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
4.72×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

MIAX
MIAX

Transferred At Point In Time$246.7M73%
Transferred Over Time$29.9M9%
Access Fees$27.1M8%
Futures Segment$19.4M6%
Other$9.1M3%
TISEG$4.7M1%

Related Comparisons